div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: Development of low endtoxin gelatin for regenerative medicine src=https:reader038fdocumentsnetreader038viewer2022102919589ec9401a28abf9498be431html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: Development of low endtoxin gelatin for regenerative medicine src=https:reader038fdocumentsnetreader038viewer2022102919589ec9401a28abf9498be431html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: Development of low endtoxin gelatin for regenerative medicine src=https:reader038fdocumentsnetreader038viewer2022102919589ec9401a28abf9498be431html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: Development of low endtoxin gelatin for regenerative medicine src=https:reader038fdocumentsnetreader038viewer2022102919589ec9401a28abf9498be431html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: Development of low endtoxin gelatin for regenerative medicine src=https:reader038fdocumentsnetreader038viewer2022102919589ec9401a28abf9498be431html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdiv